Pfizer Inc (NYSE:PFE)
| 40.79 Delayed Data As of Mar 31 |  +0.41 / +1.02%Today’s Change | 39.23 Today|||52-Week Range 56.32 | -20.39% Year-to-Date |
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 40.38 |
| Today’s open | 40.50 |
| Day’s range | 40.28 - 40.83 |
| Volume | 23,393,576 |
| Average volume (3 months) | 21,940,890 |
| Market cap | $228.0B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +41.45% |
| Earnings growth (this year) | -44.98% |
| Earnings growth (next 5 years) | -0.50% |
| Revenue growth (last year) | +23.43% |
| P/E ratio | 7.5 |
| Price/Sales | 2.93 |
| Price/Book | 2.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.22 | +0.31% |
| NVSNovartis | +0.41 | +0.45% |
| MRKMerck | +0.42 | +0.40% |
| NVONovo Nordisk | +1.06 | +0.67% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 2, 2023 |
| EPS forecast (this quarter) | $0.99 |
| Annual revenue (last year) | $100.3B |
| Annual profit (last year) | $31.4B |
| Net profit margin | 31.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
